NCT01634165View on ClinicalTrials.gov

A Study of LY2963016 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

LY2963016

Administered subcutaneously

DRUG

Lantus

Administered subcutaneously

Trial Locations (1)

117597

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01634165 - A Study of LY2963016 in Healthy Participants | Biotech Hunter | Biotech Hunter